folder

Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils

Authors

  • J. Bieschke
  • M. Herbst
  • T. Wiglenda
  • R.P. Friedrich
  • A. Boeddrich
  • F. Schiele
  • D. Kleckers
  • J.M. Lopez Del Amo
  • B.A. Gruening
  • Q. Wang
  • M.R. Schmidt
  • R. Lurz
  • R. Anwyl
  • S. Schnoegl
  • M. Faendrich
  • R.F. Frank
  • B. Reif
  • S. Guenther
  • D.M. Walsh
  • E.E. Wanker

Journal

  • Nature Chemical Biology

Citation

  • Nat Chem Biol 8 (1): 93-101

Abstract

  • Several lines of evidence indicate that prefibrillar assemblies of amyloid-{beta} (A{beta}) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of A{beta} fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in A{beta} peptides and stabilizes the self-assembly of seeding-competent, {beta}-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic A{beta} oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by A{beta} oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.


DOI

doi:10.1038/nchembio.719